The DeCell technology creates a patch of human skin, between one and four centimetres square, that is sterilized then fitted over the ulcer. It is also processed to remove the foreign cellular material that typically leads to rejection when skin grafts are used. This skin "scaffold" allows the patient's own tissue to regenerate around and within it until the scaffold is replaced by the patient's own cellular material.
| Website | http://www.decelltechnologies.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2000 |
| Address | 1344 Summer St Ste 210, Halifax, Nova Scotia B3H 0A8, CA |
| Phone | +1 902-442-4668 |
| Industry | Retail, Manufacturing, Medical Supplies, Medical Device, Other Devices and Supplies, Health Care |
| Competitors | Medtronic, Smith+Nephew, Bio-Tissue, Organogenesis, Acelity, REGENESIS Remediation Solutions - Corporate, Cellerant Therapeutics, VERCIDA Group, Dharma Computers +39 more (view full list) |
| SIC | SIC Code 267 Companies, SIC Code 26 Companies |
| NAICS | NAICS Code 3222 Companies, NAICS Code 32 Companies, NAICS Code 322 Companies |
Looking for a particular DeCell Technologies Inc. employee's phone or email?
DeCell Technologies Inc. Questions
The DeCell Technologies Inc. annual revenue was $5 million in 2026.
DeCell Technologies Inc. is based in Halifax, Nova Scotia.
The NAICS codes for DeCell Technologies Inc. are [3222, 32, 322].
The SIC codes for DeCell Technologies Inc. are [267, 26].
